Initial Results of a Phase 2 Study of Venetoclax Added to Ibrutinib to Eliminate Ibrutinib Resistance Mutations in CLLKerry A Rogers,Eric McLaughlin,Lai Wei,Seema A Bhat, Arianna Crouse,Michael R. Grever,Dan Jones,Adam S Kittai,Gerard Lozanski,Mollie Moran,Mark Reid,Ellen J Sass, Swetha Suresh,John C. Byrd,Jennifer A. WoyachBlood(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要